- Популярные видео
- Авто
- Видео-блоги
- ДТП, аварии
- Для маленьких
- Еда, напитки
- Животные
- Закон и право
- Знаменитости
- Игры
- Искусство
- Комедии
- Красота, мода
- Кулинария, рецепты
- Люди
- Мото
- Музыка
- Мультфильмы
- Наука, технологии
- Новости
- Образование
- Политика
- Праздники
- Приколы
- Природа
- Происшествия
- Путешествия
- Развлечения
- Ржач
- Семья
- Сериалы
- Спорт
- Стиль жизни
- ТВ передачи
- Танцы
- Технологии
- Товары
- Ужасы
- Фильмы
- Шоу-бизнес
- Юмор
AI in Drug Discovery: How Scientists are Leveraging Technology in Biotech Research
AI in drug discovery is reshaping biotechnology, precision medicine, and pharmaceutical R&D. In this episode of Meeting the Moment, scientists from Amgen, MIT, and Harvard explore how artificial intelligence, machine learning, protein modeling, and computational biology are changing the future of medicine development.
Moderated by Charles Lin, Executive Director at Amgen, this roundtable discussion examines some of the biggest questions in AI-driven drug discovery and biomedical research:
• Can AI accelerate the discovery and development of new medicines?
• How are protein language models and AlphaFold transforming drug discovery?
• What role do generative AI, predictive modeling, and biological datasets play in therapeutic development?
• Where does human expertise remain essential in AI-powered science?
The panel explores the opportunities and limitations of AI in biotech, including biological complexity, protein interactions, immunogenicity, data quality, computational biology, and translating AI predictions into real-world therapies.
Featuring experts from Amgen, MIT, and Harvard Medical School, this conversation covers:
-AI in biotech and pharmaceutical innovation
-Machine learning for drug discovery
-Protein engineering and protein structure prediction
-Computational biology and systems biology
-AI-driven target discovery and molecular design
-Precision medicine and the future of therapeutics
Whether you work in biotechnology, pharma, AI research, bioinformatics, computational chemistry, or healthcare innovation, this discussion explores where AI is already making an impact — and what breakthroughs may come next.
Subscribe to the Amgen YouTube Science channel for more conversations on AI, drug development, biomedical innovation, and the future of medicine.
Panelists include Angela Koehler (PhD, Associate Director for Integrative Cancer Research, MIT), Sergey Ovchinnikov (PhD, Assistant Professor, MIT), Debora Marks (PhD, Professor, Harvard) and Kaiyi Jiang (PhD, Science Fellow, Amgen)
Find Amgen on the Web:
Facebook: https://bit.ly/35Xf09E
Instagram: https://bit.ly/2SYnTKJ
X: https://bit.ly/2SW2cLq
LinkedIn: https://bit.ly/2xWbS17
Видео AI in Drug Discovery: How Scientists are Leveraging Technology in Biotech Research канала Amgen
Moderated by Charles Lin, Executive Director at Amgen, this roundtable discussion examines some of the biggest questions in AI-driven drug discovery and biomedical research:
• Can AI accelerate the discovery and development of new medicines?
• How are protein language models and AlphaFold transforming drug discovery?
• What role do generative AI, predictive modeling, and biological datasets play in therapeutic development?
• Where does human expertise remain essential in AI-powered science?
The panel explores the opportunities and limitations of AI in biotech, including biological complexity, protein interactions, immunogenicity, data quality, computational biology, and translating AI predictions into real-world therapies.
Featuring experts from Amgen, MIT, and Harvard Medical School, this conversation covers:
-AI in biotech and pharmaceutical innovation
-Machine learning for drug discovery
-Protein engineering and protein structure prediction
-Computational biology and systems biology
-AI-driven target discovery and molecular design
-Precision medicine and the future of therapeutics
Whether you work in biotechnology, pharma, AI research, bioinformatics, computational chemistry, or healthcare innovation, this discussion explores where AI is already making an impact — and what breakthroughs may come next.
Subscribe to the Amgen YouTube Science channel for more conversations on AI, drug development, biomedical innovation, and the future of medicine.
Panelists include Angela Koehler (PhD, Associate Director for Integrative Cancer Research, MIT), Sergey Ovchinnikov (PhD, Assistant Professor, MIT), Debora Marks (PhD, Professor, Harvard) and Kaiyi Jiang (PhD, Science Fellow, Amgen)
Find Amgen on the Web:
Facebook: https://bit.ly/35Xf09E
Instagram: https://bit.ly/2SYnTKJ
X: https://bit.ly/2SW2cLq
LinkedIn: https://bit.ly/2xWbS17
Видео AI in Drug Discovery: How Scientists are Leveraging Technology in Biotech Research канала Amgen
Комментарии отсутствуют
Информация о видео
7 ч. 43 мин. назад
00:31:30
Другие видео канала





















